Dr. Rahuljit Singh Bajwa, MD

Dr. Bajwa practices at Manteca Medical Center in Manteca, California, part of Kaiser Permanente.

Dr. Bajwa's NPI, 1366763906, was assigned on June 17, 2010. Dr. Bajwa graduated from Sri Guru Ram Das Institute of Medical Sciences & Research in 2003. Dr. Bajwa's New York license number on file is 270712.

Dr. Bajwa's primary practice is Manteca Medical Center, at 1777 West Yosemite Ave, Manteca, CA 95337 in San Joaquin County. The practice phone is (209) 825-3700.

Dr. Bajwa's primary practice is Manteca Medical Center in Manteca, California, part of Kaiser Permanente. Dr. Bajwa is also affiliated with Rochester General Hospital. The medical group on file is The Permanente Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bajwa practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Bajwa's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Bajwa is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bajwa's licenses on file in 4 states: New York, California, Connecticut and Massachusetts.

CMS data shows 41 Medicare services from Dr. Bajwa across 1 procedure code in 2024, for 52 Medicare patients. Medicare paid $254 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Bajwa in 2024. The largest group is under 65, with 18 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bajwa's median patient age at 59, with 52% women.

In 2024, Dr. Bajwa wrote 943 Medicare Part D claims for 265 patients. 83% of them were for generic drugs. CMS names the drug for 843 of them, across 23 drugs with 11 or more claims each, at $171,173 in total drug cost. In 2023, CMS named 1,082 claims across 25 drugs.

Dr. Bajwa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bajwa as offering telehealth.

CMS Open Payments shows 18 general payments to Dr. Bajwa from 7 drug and device companies from 2017 to 2024. Education make up the largest share, 50% of the total. Medtronic Vascular, Inc. paid the most, $193.

Dr. Bajwa graduated from Sri Guru Ram Das Institute of Medical Sciences & Research in 2003.

Dr. Bajwa is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.